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New findings suggest that transcription enhancers work by recruitment of a large dynamic network of coactivators and other factors responsible for gene activation. Formation of these condensates is driven by DNA-bound transcription factors, their intrinsically disordered activation domains, and dynamic low-specificity interactions within the complex.
The mechanism of transcriptional regulation by enhancers has been difficult to understand. Transcription factors binding to these elements somehow regulate transcription initiation and subsequent events many thousands of base pairs distant from target genes. Adding to this confusion, the activation domains contained within these enhancer-binding factors are intrinsically disordered, contain no common conserved amino acid sequence motifs, and often bind their target proteins with relatively low affinity and specificity. How can such weak low-specificity interactions combine to precisely regulate patterns of gene expression that direct complex processes such as development, growth regulation, and stress response? Over the past few years, there has been an explosion of discoveries at the molecular level concerning how intrinsically disordered proteins function in molecular recognition and how they contribute to enhancer function by promoting dynamic cellular condensates. Several very recent papers (Cho et al., 2018; Chong et al., 2018; Sabari et al., 2018) , including one from the Young lab in this issue of Cell , have led to a new paradigm for enhancer function in which enhancers recruit and concentrate large numbers of transcription factors, coactivators, and at least some components of the basal transcription machinery into dynamic complexes. This compartmentalization mechanism turns the weak and low-specificity properties of intrinsically disordered proteins into a strength, effectively increasing the specificity of interactions while retaining the dynamic nature of the complex.
The work on the role of cellular condensates in enhancer function began with the goal of understanding how super enhancers function. In contrast to the many thousands of typical cellular enhancers that are usually a few hundred base pairs in length, cells contain several hundred cell-type-specific super enhancers (Whyte et al., 2013) , which contain large clusters of transcription-factor binding sites that span tens of thousands of base pairs. Super enhancers drive expression of genes that define cell identity and nucleate a high density of colocalized factors such as the coactivator Mediator, RNA polymerase II (Pol II), and other factors responsible for gene activation and chromatin architecture. Based on these and other properties, it has been proposed that super enhancers promote liquid-liquid phase transition, a widely used mechanism to form non-membrane-bound compartments and reversibly organize molecules within cells (Hnisz et al., 2017) . Many phase-separated compartments show liquid-like characteristics such as round shape, dynamic internal components, and the ability to flow, drip, and fuse. Formation of these condensates, in which the components are concentrated relative to the surroundings, is driven by weak and dynamic multivalent interactions. This model potentially explains an important role for intrinsic disorder, a feature of key proteins within liquid-like compartments, the basis for cooperativity of transcription factors in the activity of a typical enhancer, and the ability of a single enhancer to simultaneously activate two linked genes.
In a first direct test of this model, the Cisse and Young groups used advanced live-cell imaging methods to detect cellular condensates associated with several super-enhancer-controlled genes that contain Mediator, Pol II and the superenhancer-binding transcription factor Brd4 (Cho et al., 2018; Sabari et al., 2018) . The condensates were shown to occur at sites of active transcription, a known property of active enhancers. Intrinsically disordered proteins often contain low-amino-acid-sequence complexity domains that have a tendency to phase separate. Consistent with the phase separation model, the intrinsically disordered regions of both Med1 (a Mediator subunit) and Brd4 form liquid droplets in vitro. In the present work, Boija et al. show that the transcription factor Oct4, another key component of mouse embryonic stem cell super enhancers, is also localized within the super enhancer condensates and that these dissolve upon depletion of Oct4 protein.
In a series of in vitro experiments, the propensity of Med1 and eight mammalian TFs for droplet formation is assessed. Many of the transcription factors form droplets on their own and all are incorporated into droplets along with Med1 when mixed. This property also extends to the yeast system where the tandem activation domains from the transcription factor Gcn4 and the Mediator subunit Med15 form mixed droplets. In some of the above cases, heavily mutated activation domains lose the ability to form droplets, concurrent with loss of transcription activation function, although derivatives with fewer total mutations will be necessary to establish if these two properties are interdependent.
In an independent study (Chong et al., 2018) , the Tjian and Darzaq groups use live-cell imaging to examine the in vivo interactions of two distinct transcriptionfactor low-complexity domains: the FET family (FUS, EWS, and TAF15) and Sp1. Upon recruitment of DNA binding domain-low-complexity domain fusions to large artificial arrays and natural microsatellite repeats, they observe phaseseparated condensates that are termed ''interaction hubs'' in which the resident transcription factors are in significant excess over the number of binding sites. These hubs recruit Pol II and show dynamic behavior with residence times on the order of seconds. The interactions between low-complexity domains exhibit specificity, as those from the FET family, but not from Sp1, could colocalize. Finally, one heavily mutated lowcomplexity domain loses both the ability to efficiently form hubs and to activate transcription. While these studies were not designed to probe the structure and physical nature of the hubs, liquid-like properties including spherical shape and local changes in refractive index are not observed. While more work will be required to address the question of liquid-like properties in all the phaseseparated systems discussed above, it is clear that droplet formation is sensitive to protein concentration and other variables so that liquid droplet formation in vitro does not necessarily translate to droplet formation in vivo. Focusing on this question, however, is missing the larger picture: that enhancers and their resident transcription factors recruit a large mass of factors required for gene activation in a dynamic complex. This is a new way of thinking about enhancer function compared to the old models where one enhancer targeted one promoter via a single coactivator, such as Mediator.
Much recent work on molecular recognition mechanisms used by intrinsically disordered proteins fits nicely with these results and potentially explains why they are key components of the condensates. For example, the tandem activation domains from Gcn4 use a dynamic fuzzy binding mechanism to target four activator-binding domains on the Mediator subunit Med15 (Tuttle et al., 2018) . Fuzzy binding is a widely used mechanism in recognition by intrinsically disordered proteins in which there is no unique protein-protein interface in the bound state, with rapid conformational exchange between different binding modes (Fuxreiter, 2018) . In the case of Gcn4-Med15, the individual activation domains appear to interact with individual activator binding domains via a cloud of hydrophobicity rather than sequence-specific interactions (Tuttle et al., 2018) . Such a dynamic binding mechanism can easily be scaled so that one transcription factor can simultaneously recruit multiple copies of one or more coactivators and other binding partners, potentially explaining how a large number of molecules are found in condensates compared to the number of transcription-factor binding sites (Figure 1) .
These new findings, while explaining the nature of large super-enhancers, raise the question of whether typical enhancers also work by this mechanism, but on a smaller scale. This may be challenging to address by current imaging methods due to the abundance of cellular enhancers and the relatively smaller number of factors at each typical enhancer. Second, what is the biological function of the condensates? Does the high concentration of factors at an enhancer make the search for its target promoters more efficient, increase specificity of the interactions by compartmentalization, or work by other mechanisms? Third, what are the components of the condensates? Phase-shifted bodies such as stress granules contain hundreds of different proteins, so it will be important to characterize these enhancer complexes in order to understand their function. Typical condensates contain a few key proteins essential for droplet formation that recruit other components (Ditlev et al., 2018) . So far, nearly all tested components of the super-enhancer condensates are important for condensate formation (Mediator, Brd4, and Oct4, but not Pol II). Fourth, what are the properties of activation domains that promote formation of these dynamic complexes?
For example, what sequences can function as activation domains, what is their biochemical specificity, and what combinations of them can function together to generate an active enhancer? Combined with the exciting new studies, answers to these and other questions raised by this new work will pull back the curtain on the longstanding mysteries of enhancer function and how they orchestrate complex patterns of gene control leading to the great diversity of complex organisms. The full alphabet of the epitranscriptome does not lend itself to easy discovery yet is still steadily unraveling. As such, the rumors about its shrinkage appear to have been considerably exaggerated. The study by Arango et al. (2018) in this issue of Cell is the latest in a series of studies that dissolve these rumors. Over 140 modifications decorate highly abundant RNA species such as rRNA and tRNA across archaea, bacteria, and eukarya. Since thousands of N 6 -methyladenosine (m 6 A) sites in eukaryotic mRNA and long noncoding RNA (lncRNA) were mapped in 2012 (Dominissini et al., 2012) , ever more modifications have been identified and characterized to varying extents in these low-abundance RNA molecules, collectively termed the epitranscriptome. Modifications embed transcripts with information additional to that carried in their sequence of bases and regulate processing events as diverse as splicing, transport, translation, and turnover (Roundtree et al., 2017) .
To this date, nine internal modifications have been documented in mRNA and lncRNA: m 6 A, N 1 -methyladenosine, inosine, pseudouridine, 5-methylcytidine, 5-hydroxymethylcytidine, N 6 ,2 0 -O-dimethyladenosine, 3-methylcytidine, and 2 0 -O-methyl. Modifications are dynamic and subject to regulation that can, in principle, act at the level of deposition, removal, or binding. Methyltransferases and demethylases, for instance, can be recruited to specific transcripts or chromatin addresses by cell-state-specific transcription factors and other adaptor proteins. The concept of epitranscriptomic regulation was driven by m 6 A, which remains the best explored modification and the only one that appears to have a dedicated enzymatic machinery not shared with other classes of RNA. Other modifications are taking their first strides, awaiting finer mapping and discovery of writes, erasers, or readers that will facilitate functional and mechanistic investigation.
Here enters the study by Arango et al. (2018) with a new modified base in human mRNA, N 4 -acetylcytidine (ac 4 C), and joins a recent preprint report that used mass spectrometry to detect ac 4 C in mRNA of the yeast Saccharomyces cerevisiae (Tardu et al., 2018) . The new field of epitranscriptomics is experiencing growing pains, a natural result of the demanding experimental and bioinformatic need to identify a relatively weak signal in rare molecules that is more often than not invisible to reverse transcription. For example, m 6 A exists in mRNA at a frequency of approximately 1-2 per 1,000 nucleotides and to
